ContractManufacturing Services Agreement • April 16th, 2014 • Ulthera Inc • Electromedical & electrotherapeutic apparatus • Florida
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
MANUFACTURING AGREEMENTManufacturing Agreement • April 16th, 2014 • Ulthera Inc • Electromedical & electrotherapeutic apparatus • Delaware
This Manufacturing Agreement (this “Agreement”) is made as of January 2nd, 2014 (the “Effective Date”), by and between BIT Group Inc., a California corporation, with offices located at 15870 Bernardo Center Drive, San Diego, CA 92127 (“BIT”), and Ulthera, Inc., a Delaware corporation, with offices located at 1840 S. Stapley Dr., Ste. 200, Mesa, AZ 85204 (“Client”). Individually, BIT and Client may be referred to herein as a “Party” and collectively as “Parties”.
THIRD AMENDED AND RESTATED LICENSE AND DEVELOPMENT AGREEMENTAnd Development Agreement • April 16th, 2014 • Ulthera Inc • Electromedical & electrotherapeutic apparatus • Arizona
This THIRD AMENDED AND RESTATED LICENSE AND DEVELOPMENT AGREEMENT (the “Third Restated Agreement”) is made effective as of August 26, 2013 (the “Effective Date”) by and among Guided Therapy Systems, LLC, an Arizona limited liability company (“GTS” or “Licensor”), Ardent Sound Inc., an Arizona corporation (“Ardent Sound” and, together with GTS, “Licensors”), and Ulthera, Inc., a Delaware corporation (“Ulthera” or “Licensee”). GTS or GTS and Ardent Sound, collectively, are hereinafter referred to as a “Party,” Ulthera is hereinafter referred to as a “Party,” and each of GTS, Ardent Sound and Ulthera are hereinafter collectively referred to as the “Parties.”
CONFIDENTIAL TRANSITION AND SEPARATION AGREEMENTConfidential Transition and Separation Agreement • April 16th, 2014 • Ulthera Inc • Electromedical & electrotherapeutic apparatus • Arizona
This Confidential Transition and Separation Agreement (the “Agreement”) is made by and between James Atkinson (“Employee”) and Ulthera, Inc., a Delaware corporation (the “Company”), effective as of the eighth (8th) day following Employee’s execution of the Agreement without revocation (the “Effective Date”). Employee and the Company are collectively referred to as the “Parties.”
